期刊名称:MOLECULAR GENETICS & GENOMIC MEDICINE
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal

Aims and Scope
Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care.
Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented.
Molecular Genetics & Genomic Medicine is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. Authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher. To find out which Created Commons Licenses are available for the journal, click here. For further information, visit the Wiley Open Access website.
Open Access and Copyright All articles published by Molecular Genetics & Genomic Medicine are fully open access: immediately freely available to read, download and share. All Molecular Genetics & Genomic Medicine articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Copyright on any research article in a journal published by Molecular Genetics & Genomic Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information about open access license and copyright can be found here.
Peer review policy Molecular Genetics & Genomic Medicine maintains the highest standards of peer review while increasing the efficiency of the process. All research articles published in the journal will undergo full peer review. We will do our utmost to judge research objectively on its own merits and to avoid favoring research, for example, from particular institutions, countries, or regions. Key characteristics of the journal’s review process are: • All research articles submitted directly to the Journal are initially evaluated by the Editor-in-Chief, and articles found appropriate for the Journal will be reviewed by at least two suitably qualified experts. • All submissions transferred to the Journal from partnering journals are evaluated by the Editors and if considered appropriate, will also be sent out for peer review by at least two qualified experts. • All publication decisions are made by the Editor-in-Chief on the basis of the reviews provided. • Members of the editorial board lend insight, advice and guidance to the Editor-in-Chief generally and assist in decision making on specific submissions. • The managing editor and editorial assistant provide administrative support to ensure Molecular Genetics & Genomic Medicine maintains the integrity of peer review and delivers rapid and efficient publication to authors and reviewers.
Referred papers In addition to papers submitted directly to the journal, Molecular Genetics & Genomic Medicine will also consider papers referred from other Wiley journals that are participating in the Manuscript Transfer Program. As part of our commitment to speed of publication, and in order to reduce strain on the peer review system, we have set-up a mechanism to allow a select group of prestigious partner journals to refer high-quality manuscripts to Molecular Genetics & Genomic Medicine, along with any existing peer review reports, when these journals are not themselves able to accommodate the manuscripts (for example, on grounds of scope or space). For such manuscripts that have existing peer review reports, our Editor-in-Chief is able to decide whether or not a manuscript is suitable for publication particularly quickly. Molecular Genetics & Genomic Medicine editors will make prompt accept, reject, or request revisions decisions, based on the original peer reviews. The Molecular Genetics & Genomic Medicineeditors may seek additional reviews and authors will be advised in those cases.
Abstracting and Indexing Information
- Academic Search Alumni Edition (EBSCO Publishing)
- Academic Search Elite (EBSCO Publishing)
- Academic Search Ultimate (EBSCO Publishing)
- Biotechnology Source (EBSCO Publishing)
- CAS: Chemical Abstracts Service (ACS)
- MEDLINE/PubMed (NLM)
- PubMed via PMC deposit (NLM)
- Science Citation Index Expanded (Clarivate Analytics)
- SCOPUS (Elsevier)
- STM Source (EBSCO Publishing)
- Web of Science (Clarivate Analytics)
Instructions to Authors
- Submission
- Aims and Scope
- Manuscript Categories and Requirements
- Preparing the Submission
- Editorial Policies and Ethical Considerations
- Author Licensing
- Publication Process After Acceptance
- Post-Publication
- Editorial Office Contact Details
Editorial Board
EDITOR-IN-CHIEF
Suzanne Hart* (National Human Genome Research Institute, NIH, Bethesda, Maryland, USA; Email: MGGM@wiley.com)
*Dr. Hart serves in her own capacity
ASSOCIATE EDITORS
Paul Kruszka* (National Human Genome Research Institute, NIH, Bethesda, Maryland, USA)
Yingze Zhang (University of Pittsburgh, Pennsylvania, USA)
*Dr. Kruszka serves in his own capacity
FOUNDING EDITOR
Maximilian Muenke* (National Human Genome Research Institute, NIH, Bethesda, Maryland, USA)
*Dr. Muenke serves in his own capacity
EDITORIAL BOARD
Eleni Aklillu (Karolinska Institutet, Sweden)
Fowzan S. Alkuraya (College of Medicine, Alfaisal University, Saudi Arabia)
Yair Anikster (Sheba Medical Center, Israel)
Mauricio Arcos-Burgos (Universidad del Rosario, Colombia)
Nurten A. Akarsu (Hacetepe University, Turkey)
Michael Bamshad (University of Washington School of Medicine, USA)
Kym Boycott (Children's Hospital of Eastern Ontario and University of Ottawa, Canada)
María Leonor Bustamente Calderón (University of Chile, Chile)
Ronald D. Cohn (University of Toronto, Canada)
Véronique David (University of Rennes, France)
Mauricio De Castro (Air Force Medical Genetics Center, USA)
Michael J. Gambello (Emory University, USA)
Andrea Gropman (Children's National Medical Center, USA)
Ophir Klein (University of California, San Francisco, USA)
Robert Kleta (University College London, United Kingdom)
Stanislav Kmoch (Charles University in Prague, Czech Republic)
Maria Rita Passos-Bueno (University of Sao Paulo, Brazil)
Shubha R. Phadke (Sanjay Gandhi Postgraduate Institute of Medical Sciences, India)
Bruno Reversade (A*STAR, Singapore)
Lisa A. Schimmenti (Mayo Clinic, USA)
Vorasuk Shotelersuk (Chulalongkorn University, Thailand)
Anne Slavotinek (University of California, San Francisco, USA)
Joris Veltman (Radboud University Nijmegen Medical Centre, The Netherlands)
Bernd Wollnik (Institute of Human Genetics Gottingen, Germany)
|